ACE2 overexpression in smooth muscle cells |
SHRSP |
↑aortic ACE2 activity |
Improved endothelial function |
Rentzsch et al19
|
↑Ang-(1-7) plasma/aorta |
↑Ang-(1-7)/Ang II |
Lentiviral ACE2 gene transfer in hearts |
SHR |
↑cardiac ACE2 mRNA |
BP independent cardioprotection |
Diez-Freire et al16
|
↑cardiac ACE2 activity |
ACE2 overexpression in hearts |
FVB/NTac |
↑serum ACE2 activity |
Cardiac rhythm disturbances and sudden death |
Donoghue et al11
|
↑cardiac ACE2 expression |
Adenoviral ACE2 gene transfer in hearts |
SHRSP |
↑cardiac ACE2 activity |
Severe cardiac fibrosis |
Masson et al22
|
↑Ang-(1-7) expression |
↓ACE activity |
ACE2 knockout |
Mixed background |
↑cardiac/plasma/renal Ang II |
↓BP and impaired systolic function |
Crackower et al8
|
ACE2 knockout |
Mixed background |
No basal changes |
Variable |
Gurley et al12
|
ACE2 knockout |
Mixed background |
No basal changes |
No basal changes |
Yamamoto et al61
|
Mas knockout |
C57BL/6 |
↓Ang-(1-7) binding in cardiac myocytes |
Impaired heart function and cardiac fibrosis |
Santos et al13
|
Mas knockout |
C57BL/6 |
Not determined |
↑sympathetic tonus |
Walther et al62
|
Mas knockout |
C57BL/6 |
Not determined |
Impaired Ang-(1-7)-mediated aortic relaxation |
Peiró et al63
|
Mas knockout |
FVB/N |
Not determined |
↑BP, impaired endothelial function and ↓NO and eNOS |
Xu et al64
|